AIBioTech provides drug discovery and diagnostic development organizations a broad range of world-class laboratory services to bring new products to market. Led by Bill Miller, CEO, Robert B. Harris, PhD, President and CSO, and Thomas Reynolds, Executive Vice President, AIBioTech is one of the world's most comprehensive Contract Research Organizations in operation. AIBioTech provides reliable expertise and cutting-edge technologies which are not available from other companies.

Find out more about AIBioTech

AIBiotech has provided automated DNA sequencing services on a commercial basis since 1992. We are pleased to announce that we have expanded and modernized our capabilities and now offer state-of-the-art Next Generation Sequencing (NGS) analysis on the Roche 454 platform. We have extensive experience and can provide custom project design and support. AIBiotech is CAP/CLIA certified and our sequencing services meets all of the requirements needed for CLIA and/or GLP regulatory compliance. We routinely are involved in Biodefense and Forensic related investigations requiring NGS. Let AIBioTech help you successfully complete your NGS project.

Learn more about our services

AIBioTech now offers state-of-the-art 2C19 testing with the most comprehensive panel in the market